§7672 — Title 22 Foreign Relations and Intercourse | U.S. Code

Summary

Congress says the United States should rapidly expand access to antiretroviral treatment through U.S. aid programs. The targets are: by the end of fiscal year 2004 at least 500,000 people, by the end of fiscal year 2005 at least 1,000,000 people, and by the end of fiscal year 2006 at least 2,000,000 people receiving treatment. Congress also says 10 percent of the money authorized for HIV/AIDS aid should go to orphans and vulnerable children.

Title 22, §7672

Foreign Relations and Intercourse — Source: USLM XML via OLRC

(a)It is a sense of the Congress that an urgent priority of United States assistance programs to fight HIV/AIDS should be the rapid increase in distribution of antiretroviral treatment so that—

(1)by the end of fiscal year 2004, at least 500,000 individuals with HIV/AIDS are receiving antiretroviral treatment through United States assistance programs;

(2)by the end of fiscal year 2005, at least 1,000,000 such individuals are receiving such treatment; and

(3)by the end of fiscal year 2006, at least 2,000,000 such individuals are receiving such treatment.

(b)It is the sense of Congress that, of the amounts appropriated pursuant to the authorization of appropriations under section 7671 of this title for HIV/AIDS assistance, 10 percent should be used for orphans and vulnerable children.

Notes & Related Subsidiaries

Editorial Notes

Amendments

2008—Subsec. (b). Pub. L. 110–293 substituted “10 percent should be used” for “an effective distribution of such amounts would be— “(1) 55 percent of such amounts for treatment of individuals with HIV/AIDS; “(2) 15 percent of such amounts for palliative care of individuals with HIV/AIDS; “(3) 20 percent of such amounts for HIV/AIDS prevention consistent with section 2151b–2(d) of this title, of which such amount at least 33 percent should be expended for abstinence-until-marriage programs; and “(4) 10 percent of such amounts”.

§7672 Sense of Congress

Summary

Title 22, §7672

Notes & Related Subsidiaries

Editorial Notes

Amendments

Citations & Metadata